Previous Close | 0.5100 |
Open | 0.5300 |
Bid | 0.5000 x 0 |
Ask | 0.5100 x 0 |
Day's Range | 0.5100 - 0.5300 |
52 Week Range | 0.4600 - 1.0500 |
Volume | |
Avg. Volume | 21,434 |
Market Cap | 45.121M |
Beta (5Y Monthly) | 1.44 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0720 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.63 |
VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / S andy MacDougall, CEO of Noram Lithium Corp. (" Noram " or the " Company ") (TSXV:NRM | OTCQB:NRVTF | Frankfurt:N7R) is pleased to announce the successful completion of CVZ-81 (PH-03) and release of the final assay results.
VANCOUVER, BC / ACCESSWIRE / June 23, 2022 / Sandy MacDougall, CEO of Noram Lithium Corp. ("Noram" or the "Company") (TSX.
VANCOUVER, BC / ACCESSWIRE / June 9, 2022 / Sandy MacDougall, CEO of Noram Lithium Corp. ("Noram" or the "Company") (TSXV:NRM | OTCQB:NRVTF | Frankfurt:N7R) is pleased to announce the successful completion of CVZ-77 (PH-04) and CVZ-78 (PH-11) and release of the final assay results.